Want to join the conversation?
$MON 3Q15 Call – Hugh, CEO: Monsanto & Syngenta combination represents the optimal solution. We believe we are in best the position to drive opportunity.Current proposal offers a significant premium; more than 30% over the three-year average price, a 43% premium vs. an unaffected stock price, & 45% premium over 12-month weighted average stock price
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?